Gardasil vaccine is now globally recognised as an effective and safe vaccine against cervical cancer.
Like all vaccines, it was extensively tested and trialed for safety before release to approval by the National Health and Medical Research Council (NHMRC).
The vaccine is subject to ongoing safety surveillance by various authorities, at least one of which, the United States Food and Drug Administration (FDA), which monitors all data on adverse affects on an ongoing basis and also publishes such data which is available to the public.
Public statements by the Australian Federal Government Department of Health and Ageing (DHA), FDA, and the European Medicines Agency (EMEA) have all restated the safety and effectiveness of the vaccine.
Related Posts
